Metraipolis › archive › dc_bb24dd10e2ee

Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative… — Europe PMC PMID:41608074

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41608074
DOI: 10.1016/j.btre.2026.e00946
License (as archived): solo-consultazione
Archived: 2026-11-06T21:04:00.355Z
SHA-256 of the archived text: 57a222a00b5df63ec5ced0b40bc923bfa1a3de07b69e7839c577869d6f609f70
Stable URL of this page: https://metraipolis.com/documento/dc_bb24dd10e2ee

How to cite

Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative… — Europe PMC PMID:41608074 — Europe PMC (en), https://europepmc.org/article/MED/41608074 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb24dd10e2ee (Metraipolis archive dc_bb24dd10e2ee, sha256 57a222a00b5df63ec5ced0b40bc923bfa1a3de07b69e7839c577869d6f609f70)

BibTeX

@misc{dcbb24dd10e2ee,
  title = {Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative… — Europe PMC PMID:41608074},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41608074},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb24dd10e2ee; sha256 57a222a00b5df63ec5ced0b40bc923bfa1a3de07b69e7839c577869d6f609f70},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41608074. Agents can read the archived copy with the MCP tool read_document.